Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults

beginning of epidemic control

V Thornton, D Lennon, K Rasanathan, J O'Hallahan, P Oster, J Stewart, S Tilman, I Aaberge, B Feiring, H Nokleby, E Rosenqvist, Karen White, S Reid, Edward (Kim) MULHOLLAND, M Wakefield, D Martin

    Research output: Contribution to journalArticleResearchpeer-review

    Original languageEnglish
    Pages (from-to)1395-1400
    Number of pages6
    JournalVaccine
    Volume24
    Issue number9
    Publication statusPublished - 2006

    Cite this

    Thornton, V., Lennon, D., Rasanathan, K., O'Hallahan, J., Oster, P., Stewart, J., ... Martin, D. (2006). Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control. Vaccine, 24(9), 1395-1400.
    Thornton, V ; Lennon, D ; Rasanathan, K ; O'Hallahan, J ; Oster, P ; Stewart, J ; Tilman, S ; Aaberge, I ; Feiring, B ; Nokleby, H ; Rosenqvist, E ; White, Karen ; Reid, S ; MULHOLLAND, Edward (Kim) ; Wakefield, M ; Martin, D. / Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults : beginning of epidemic control. In: Vaccine. 2006 ; Vol. 24, No. 9. pp. 1395-1400.
    @article{d3338e397be34d38a7543ac5c7aaddd2,
    title = "Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control",
    author = "V Thornton and D Lennon and K Rasanathan and J O'Hallahan and P Oster and J Stewart and S Tilman and I Aaberge and B Feiring and H Nokleby and E Rosenqvist and Karen White and S Reid and MULHOLLAND, {Edward (Kim)} and M Wakefield and D Martin",
    year = "2006",
    language = "English",
    volume = "24",
    pages = "1395--1400",
    journal = "Vaccine",
    issn = "0264-410X",
    publisher = "Elsevier",
    number = "9",

    }

    Thornton, V, Lennon, D, Rasanathan, K, O'Hallahan, J, Oster, P, Stewart, J, Tilman, S, Aaberge, I, Feiring, B, Nokleby, H, Rosenqvist, E, White, K, Reid, S, MULHOLLAND, EK, Wakefield, M & Martin, D 2006, 'Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control', Vaccine, vol. 24, no. 9, pp. 1395-1400.

    Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults : beginning of epidemic control. / Thornton, V; Lennon, D; Rasanathan, K; O'Hallahan, J; Oster, P; Stewart, J; Tilman, S; Aaberge, I; Feiring, B; Nokleby, H; Rosenqvist, E; White, Karen; Reid, S; MULHOLLAND, Edward (Kim); Wakefield, M; Martin, D.

    In: Vaccine, Vol. 24, No. 9, 2006, p. 1395-1400.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults

    T2 - beginning of epidemic control

    AU - Thornton, V

    AU - Lennon, D

    AU - Rasanathan, K

    AU - O'Hallahan, J

    AU - Oster, P

    AU - Stewart, J

    AU - Tilman, S

    AU - Aaberge, I

    AU - Feiring, B

    AU - Nokleby, H

    AU - Rosenqvist, E

    AU - White, Karen

    AU - Reid, S

    AU - MULHOLLAND, Edward (Kim)

    AU - Wakefield, M

    AU - Martin, D

    PY - 2006

    Y1 - 2006

    M3 - Article

    VL - 24

    SP - 1395

    EP - 1400

    JO - Vaccine

    JF - Vaccine

    SN - 0264-410X

    IS - 9

    ER -

    Thornton V, Lennon D, Rasanathan K, O'Hallahan J, Oster P, Stewart J et al. Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control. Vaccine. 2006;24(9):1395-1400.